ICU
SeaStar Medical Holding Corp
+0.04 (+1.30%)3.12USD6.9K成交股數13.7M市值–本益比(近四季)8.0股價營收比+82.0%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 1 · 2K · 1 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 2K · 0.00 |
| 近 180 天 淨額 | 2K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 | 08-19 | Messinger Michael | Chief Financial Officer | P 公開市場買進 | 750 | 3.27 | 2K | 2.5K | SEC |
| 2026-07-01 | 07-02 | Neuman John | Director | A 獲配股票 | 4.0K | – | – | 16.2K | SEC |
| 2026-07-01 | 07-02 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 10.3K | – | – | 50.1K | SEC |
| 2026-07-01 | 07-02 | Baird Jennifer A | Director | A 獲配股票 | 4.0K | – | – | 10.6K | SEC |
| 2026-07-01 | 07-02 | Van Heel Kenneth | Director | A 獲配股票 | 4.0K | – | – | 11.9K | SEC |
| 2026-07-01 | 07-02 | Vincent Bernadette N | Director | A 獲配股票 | 4.0K | – | – | 8.2K | SEC |
| 2026-07-01 | 07-02 | Chung Kevin | Chief Medical Officer | A 獲配股票 | 7.2K | – | – | 28.0K | SEC |
| 2026-02-06 | 02-10 | Towne Bradford K | Principal Accounting Officer | A 獲配股票 | 7.5K | – | – | 9.1K | SEC |
| 2026-02-06 | 02-10 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 30.0K | – | – | 39.9K | SEC |
| 2026-02-06 | 02-10 | Chung Kevin | Chief Medical Officer | A 獲配股票 | 15.0K | – | – | 20.8K | SEC |
| 2026-02-06 | 02-10 | Baird Jennifer A | Director | A 獲配股票 | 3.0K | – | – | 6.6K | SEC |
| 2026-02-06 | 02-10 | Vincent Bernadette N | Director | A 獲配股票 | 3.0K | – | – | 4.2K | SEC |
| 2026-02-06 | 02-10 | Neuman John | Director | A 獲配股票 | 3.0K | – | – | 12.2K | SEC |
| 2026-02-06 | 02-10 | Van Heel Kenneth | Director | A 獲配股票 | 3.0K | – | – | 7.9K | SEC |
| 2025-12-19 | 12-22 | Baird Jennifer A | Director | P 公開市場買進 | 4.2K | 0.24 | 1K | 36.2K | SEC |
| 2025-12-09 | 12-11 | Messinger Michael | Chief Financial Officer | P 公開市場買進 | 14.5K | 0.35 | 5K | 17.5K | SEC |
| 2025-08-27 | 08-28 | Van Heel Kenneth | Director | P 公開市場買進 | 10.0K | 0.86 | 9K | 49.4K | SEC |
| 2025-08-26 | 08-28 | Van Heel Kenneth | Director | P 公開市場買進 | 25.0K | 0.89 | 22K | 39.4K | SEC |
| 2025-08-22 | 08-25 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 10.0K | 0.80 | 8K | 58.2K | SEC |
| 2025-07-10 | 07-16 | Baird Jennifer A | Director | A 獲配股票 | 4.0K | – | – | 32.0K | SEC |
| 2025-07-10 | 07-16 | Van Heel Kenneth | Director | A 獲配股票 | 4.0K | – | – | 14.4K | SEC |
| 2025-07-10 | 07-16 | Vincent Bernadette N | Director | A 獲配股票 | 4.0K | – | – | 12.0K | SEC |
| 2025-07-10 | 07-16 | Neuman John | Director | A 獲配股票 | 4.0K | – | – | 92.0K | SEC |
| 2025-07-01 | 07-03 | Chung Kevin | Chief Medical Officer | M 選擇權執行 | 5.0K | – | – | 48.2K | SEC |
| 2025-07-01 | 07-03 | Schlorff Eric | Chief Executive Officer | M 選擇權執行 | 21.7K | – | – | 98.5K | SEC |
| 2025-06-30 | 07-02 | Baird Jennifer A | Director | P 公開市場買進 | 10.0K | 0.42 | 4K | 28.0K | SEC |
| 2025-06-24 | 06-27 | Neuman John | Director | P 公開市場買進 | 40.0K | 0.36 | 14K | 80.0K | SEC |
| 2025-06-04 | 07-16 | Neuman John | Director | M 選擇權執行 | 2.7K | – | – | 88.0K | SEC |
| 2025-06-04 | 07-16 | Vincent Bernadette N | Director | M 選擇權執行 | 2.7K | – | – | 8.0K | SEC |
| 2025-06-04 | 07-16 | Van Heel Kenneth | Director | M 選擇權執行 | 4.0K | – | – | 10.4K | SEC |
| 2025-06-04 | 07-02 | Baird Jennifer A | Director | M 選擇權執行 | 2.7K | – | – | 18.0K | SEC |
| 2025-05-20 | 05-22 | Baird Jennifer A | Director | P 公開市場買進 | 10.0K | 1.28 | 13K | 10.0K | SEC |
| 2025-05-20 | 05-20 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 4.5K | 1.25 | 6K | 18.2K | SEC |
| 2024-12-11 | 02-27 | Neuman John | Director | P 公開市場買進 | 10.0K | 2.04 | 20K | 40.0K | SEC |
| 2024-11-18 | 11-19 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 4.3K | 1.99 | 8K | 13.7K | SEC |
| 2024-09-30 | 10-01 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 1.0K | 4.26 | 4K | 9.4K | SEC |
| 2024-08-30 | 09-09 | Green David A | Chief Financial Officer | A 獲配股票 | 8.1K | – | – | 10.3K | SEC |
| 2024-08-15 | 02-27 | Neuman John | Director | P 公開市場買進 | 10.0K | 5.24 | 52K | 30.0K | SEC |
| 2024-06-17 | 02-27 | Neuman John | Director | P 公開市場買進 | 10.0K | 4.35 | 44K | 20.0K | SEC |
| 2024-06-14 | 02-27 | Neuman John | Director | P 公開市場買進 | 10.0K | 3.69 | 37K | 10.0K | SEC |
| 2024-04-18 | 09-09 | Green David A | Chief Financial Officer | A 獲配股票 | 2.2K | – | – | 2.2K | SEC |
| 2024-04-12 | 04-16 | Green David A | Chief Financial Officer | A 獲配股票 | 753K | – | – | 753K | SEC |
| 2024-04-12 | 04-16 | Rodgers Bruce M. | Director | A 獲配股票 | 36.5K | – | – | 44.5K | SEC |
| 2024-04-12 | 04-16 | Collins Allan | Director | A 獲配股票 | 37.9K | – | – | 54.3K | SEC |
| 2024-04-12 | 04-16 | Van Heel Kenneth | Director | A 獲配股票 | 43.6K | – | – | 160K | SEC |
| 2024-04-12 | 04-16 | Barnett Rick | Director | A 獲配股票 | 70.3K | – | – | 86.7K | SEC |
| 2024-04-12 | 04-16 | Lobo Andres | Director | A 獲配股票 | 32.3K | – | – | 40.3K | SEC |
| 2024-04-12 | 04-16 | Russell Richard D. | Director | A 獲配股票 | 32.3K | – | – | 60.3K | SEC |
| 2023-11-29 | 11-29 | Chung Kevin | Chief Medical Officer | A 獲配股票 | 63.4K | – | – | 211K | SEC |
| 2023-11-29 | 11-29 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 60.2K | – | – | 838K | SEC |
| 2023-11-29 | 11-29 | Baron Caryl | Interim CFO | A 獲配股票 | 20.3K | – | – | 140K | SEC |
| 2023-11-22 | 11-27 | Van Heel Kenneth | Director | P 公開市場買進 | 100K | 0.40 | 40K | 116K | SEC |
| 2023-09-22 | 11-29 | Baron Caryl | Interim CFO | J 其他 | 15.1K | – | – | 120K | SEC |
| 2023-09-15 | 09-19 | Baron Caryl | Interim CFO | A 獲配股票 | 4.1K | – | – | 105K | SEC |
| 2023-09-15 | 09-19 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 41.1K | – | – | 780K | SEC |
| 2023-09-15 | 09-19 | Chung Kevin | Chief Medical Officer | A 獲配股票 | 34.3K | – | – | 154K | SEC |
| 2023-08-31 | 11-28 | Chung Kevin | Chief Medical Officer | A 獲配股票 | 28.1K | – | – | 113K | SEC |
| 2023-08-31 | 11-28 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 33.8K | – | – | 736K | SEC |
| 2023-08-31 | 09-12 | Baron Caryl | Interim CFO | A 獲配股票 | 3.4K | – | – | 100K | SEC |
| 2023-08-31 | 09-12 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 35.2K | – | – | 739K | SEC |
| 2023-08-31 | 09-12 | Chung Kevin | Chief Medical Officer | A 獲配股票 | 35.2K | – | – | 120K | SEC |
| 2023-08-15 | 11-28 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 20.3K | – | – | 702K | SEC |
| 2023-08-15 | 08-17 | Baron Caryl | Interim CFO | A 獲配股票 | 2.0K | – | – | 97.0K | SEC |
| 2023-08-15 | 08-17 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 21.2K | – | – | 704K | SEC |
| 2023-08-15 | 08-17 | Chung Kevin | Chief Medical Officer | A 獲配股票 | 16.9K | – | – | 85.1K | SEC |
| 2023-06-23 | 06-27 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 417K | – | – | 682K | SEC |
| 2023-06-09 | 06-13 | Baron Caryl | Interim CFO | A 獲配股票 | 56.9K | – | – | 110K | SEC |
| 2023-06-09 | 06-13 | Baron Caryl | Interim CFO | F 繳稅扣股 | 15.1K | 0.53 | 8K | 95.0K | SEC |
| 2023-05-30 | 06-01 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 1.1K | 0.48 | 552.00 | 68.1K | SEC |
| 2023-05-30 | 06-01 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 5.1K | 0.47 | 2K | 60.7K | SEC |
| 2023-05-30 | 06-01 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 4.0K | 0.48 | 2K | 64.7K | SEC |
| 2023-05-30 | 06-01 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 2.3K | 0.48 | 1K | 67.0K | SEC |
| 2023-05-25 | 05-30 | Russell Richard D. | Director | P 公開市場買進 | 20.0K | 0.50 | 10K | 28.0K | SEC |
| 2023-05-18 | 05-22 | Chung Kevin | Chief Medical Officer | P 公開市場買進 | 7.5K | 0.70 | 5K | 55.6K | SEC |
| 2023-04-06 | 04-10 | Russell Richard D. | Director | A 獲配股票 | 8.0K | – | – | 8.0K | SEC |
| 2023-04-06 | 04-10 | Lobo Andres | Director | A 獲配股票 | 8.0K | – | – | 8.0K | SEC |
| 2023-04-06 | 04-10 | Barnett Rick | Director | A 獲配股票 | 8.0K | – | – | 16.4K | SEC |
| 2023-04-06 | 04-10 | Van Heel Kenneth | Director | A 獲配股票 | 8.0K | – | – | 16.4K | SEC |
| 2023-04-06 | 04-10 | Collins Allan | Director | A 獲配股票 | 8.0K | – | – | 16.4K | SEC |
| 2023-04-06 | 04-10 | Schlorff Eric | Chief Executive Officer | A 獲配股票 | 66.5K | – | – | 265K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 49.6K | 182K | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 33.1K | 121K | 新進 | 新進 |
| UBS Group AG | 31.4K | 115K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 13.7K | 50K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 12.6K | 46K | 新進 | 新進 |
| NORTHERN TRUST CORP | 10.4K | 38K | 新進 | 新進 |
| PNC Financial Services Group, Inc. | 4.9K | 18K | 新進 | 新進 |
| Tower Research Capital LLC (TRC) | 1.4K | 5K | 新進 | 新進 |
| BlackRock, Inc. | 913 | 3K | 新進 | 新進 |
| OSAIC HOLDINGS, INC. | 195 | 714.00 | 新進 | 新進 |
| NewEdge Advisors, LLC | 176 | 647.00 | 新進 | 新進 |
| Vanguard Global Advisers, LLC | 165 | 606.00 | 新進 | 新進 |
| TD Waterhouse Canada Inc. | 22 | 106.00 | 新進 | 新進 |
| SBI Securities Co., Ltd. | 14 | 51.00 | 新進 | 新進 |
| SOA Wealth Advisors, LLC. | 6 | 22.00 | 新進 | 新進 |
| BARCLAYS PLC | 4 | 15.00 | 新進 | 新進 |
| Caitong International Asset Management Co., Ltd | 2 | 7.00 | 新進 | 新進 |
| HighMark Wealth Management LLC | 2 | 7.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 18 +1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 18 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 159K · 3.6% |
| 合計季末市值 | 582K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 111K |
|---|---|
| 與上期比 | -9.1% |
| 佔流通股數 | 2.51% |
| 日均成交量 | 47.6K |
| 回補天數 | 2.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 111K | -9.1% | 2.51% | 47.6K | 2.3 |
| 2026-08-14 | 122K | +33.5% | 2.76% | 92.0K | 1.3 |
| 2026-07-31 | 91.2K | -34.4% | 2.07% | 60.4K | 1.5 |
| 2026-07-15 | 139K | +69.6% | 3.15% | 150K | 1.0 |
| 2026-06-30 | 81.9K | -36.7% | 1.86% | 74.9K | 1.1 |
| 2026-06-15 | 129K | -8.5% | 2.93% | 102K | 1.3 |
| 2026-05-29 | 141K | -8.8% | 3.21% | 68.5K | 2.1 |
| 2026-05-15 | 155K | -28.9% | 3.52% | 89.1K | 1.7 |
| 2026-04-30 | 218K | +36.6% | 4.94% | 90.2K | 2.4 |
| 2026-04-15 | 159K | -25.9% | 3.62% | 171K | 1.0 |
| 2026-03-31 | 215K | +28.1% | 4.88% | 319K | 1.0 |
| 2026-03-13 | 168K | -28.0% | 3.81% | 57.6K | 2.9 |
| 2026-02-27 | 233K | -18.5% | 5.29% | 43.3K | 5.4 |
| 2026-02-13 | 286K | +85.5% | 6.50% | 109K | 2.6 |
| 2026-01-30 | 154K | +13.1% | 3.50% | 111K | 1.4 |
| 2026-01-15 | 136K | -86.3% | 3.10% | 182K | 1.0 |
| 2025-12-31 | 997K | -1.4% | 22.62% | 1.3M | 1.0 |
| 2025-12-15 | 1.0M | -67.1% | 22.93% | 1.6M | 1.0 |
| 2025-11-28 | 3.1M | +669.1% | 69.76% | 5.3M | 1.0 |
| 2025-11-14 | 400K | -35.2% | 9.07% | 878K | 1.0 |
| 2025-10-31 | 617K | -73.5% | 13.99% | 1.0M | 1.0 |
| 2025-10-15 | 2.3M | -54.5% | 52.80% | 2.4M | 1.0 |
| 2025-09-30 | 5.1M | +14.4% | 116.09% | 5.1M | 1.0 |
| 2025-09-15 | 4.5M | +42.9% | 101.46% | 1.1M | 4.2 |
| 2025-08-29 | 3.1M | +95.9% | 71.00% | 1.1M | 2.9 |
| 2025-08-15 | 1.6M | -22.9% | 36.25% | 1.9M | 1.0 |